ICU Medical, Incorporated (NASDAQ:ICUI) Position Lifted by TD Asset Management Inc.

Share on StockTwits

TD Asset Management Inc. raised its stake in shares of ICU Medical, Incorporated (NASDAQ:ICUI) by 26.7% during the second quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 63,645 shares of the medical instruments supplier’s stock after acquiring an additional 13,397 shares during the quarter. TD Asset Management Inc. owned approximately 0.31% of ICU Medical worth $16,033,000 at the end of the most recent quarter.

A number of other hedge funds and other institutional investors also recently bought and sold shares of the business. Quadrant Capital Group LLC lifted its position in shares of ICU Medical by 1,110.5% in the 1st quarter. Quadrant Capital Group LLC now owns 230 shares of the medical instruments supplier’s stock worth $53,000 after buying an additional 211 shares during the last quarter. Huntington National Bank lifted its position in shares of ICU Medical by 15.3% in the 2nd quarter. Huntington National Bank now owns 474 shares of the medical instruments supplier’s stock worth $119,000 after buying an additional 63 shares during the last quarter. Andesa Financial Management Inc. bought a new position in shares of ICU Medical in the 1st quarter worth about $212,000. ARP Americas LP bought a new position in shares of ICU Medical in the 1st quarter worth about $212,000. Finally, Starr International Co. Inc. bought a new position in shares of ICU Medical in the 1st quarter worth about $220,000. Hedge funds and other institutional investors own 91.31% of the company’s stock.

A number of research analysts have recently issued reports on the stock. BidaskClub downgraded shares of ICU Medical from a “buy” rating to a “hold” rating in a research report on Wednesday. Zacks Investment Research downgraded shares of ICU Medical from a “hold” rating to a “sell” rating in a research report on Wednesday. ValuEngine downgraded shares of ICU Medical from a “hold” rating to a “sell” rating in a research report on Thursday, August 8th. TheStreet downgraded shares of ICU Medical from a “b-” rating to a “c+” rating in a research report on Monday, August 12th. Finally, Raymond James downgraded shares of ICU Medical from a “strong-buy” rating to an “outperform” rating in a research report on Thursday, August 8th. Two research analysts have rated the stock with a sell rating, one has assigned a hold rating and one has given a buy rating to the company. The company presently has an average rating of “Hold” and a consensus price target of $290.50.

NASDAQ:ICUI traded down $1.03 during mid-day trading on Friday, hitting $165.99. The stock had a trading volume of 203,200 shares, compared to its average volume of 311,752. The stock has a market capitalization of $3.45 billion, a price-to-earnings ratio of 21.53 and a beta of 0.81. The company has a 50 day simple moving average of $235.88 and a 200-day simple moving average of $235.74. ICU Medical, Incorporated has a 52 week low of $160.00 and a 52 week high of $312.45.

ICU Medical (NASDAQ:ICUI) last issued its quarterly earnings data on Wednesday, August 7th. The medical instruments supplier reported $1.99 earnings per share for the quarter, beating the Thomson Reuters’ consensus estimate of $1.86 by $0.13. The firm had revenue of $312.30 million for the quarter, compared to the consensus estimate of $315.47 million. ICU Medical had a net margin of 3.56% and a return on equity of 12.41%. ICU Medical’s quarterly revenue was down 13.4% compared to the same quarter last year. During the same period last year, the firm posted $2.69 EPS. Equities research analysts anticipate that ICU Medical, Incorporated will post 7.21 EPS for the current year.

In related news, Director Robert S. Swinney sold 239 shares of ICU Medical stock in a transaction dated Monday, July 15th. The shares were sold at an average price of $248.73, for a total value of $59,446.47. Following the sale, the director now directly owns 19,662 shares in the company, valued at approximately $4,890,529.26. The sale was disclosed in a legal filing with the SEC, which is available at the SEC website. Also, CFO Scott E. Lamb sold 25,000 shares of ICU Medical stock in a transaction dated Wednesday, June 26th. The shares were sold at an average price of $250.00, for a total transaction of $6,250,000.00. Following the completion of the sale, the chief financial officer now owns 34,984 shares in the company, valued at $8,746,000. The disclosure for this sale can be found here. Over the last quarter, insiders sold 34,661 shares of company stock worth $8,354,148. 11.40% of the stock is currently owned by insiders.

ICU Medical Company Profile

ICU Medical, Inc develops, manufactures, and sells medical devices used in vascular therapy, critical care, and oncology applications worldwide. It offers infusion therapy products comprising a tube running from a bottle or plastic bag containing a solution to a catheter inserted in a patient's vein.

See Also: What are momentum indicators and what do they show?

Want to see what other hedge funds are holding ICUI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for ICU Medical, Incorporated (NASDAQ:ICUI).

Institutional Ownership by Quarter for ICU Medical (NASDAQ:ICUI)

Receive News & Ratings for ICU Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ICU Medical and related companies with MarketBeat.com's FREE daily email newsletter.